CROCS, INC., DEF 14A filed on 4/25/2025
Proxy Statement (definitive)
v3.25.1
Cover
12 Months Ended
Dec. 31, 2024
Document Information [Line Items]  
Document Type DEF 14A
Amendment Flag false
Entity Information [Line Items]  
Entity Registrant Name CROCS, INC.
Entity Central Index Key 0001334036
v3.25.1
Pay vs Performance Disclosure
12 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
Value of Initial Fixed $100 Investment
Based On:
Year
(a)
SCT Total Compensation for PEO ($)
(b)
Compensation Actually Paid to PEO ($)
(c)
Average SCT Total Compensation for Non-PEO NEOs ($)
(d)
Average Compensation Actually Paid to Non-PEO NEOs ($)
(e)
Total Shareholder Return ($)
(f)
Peer Group Total Shareholder Return ($)
(g)
Net Income ($ in millions)
(h)
Enterprise
Adjusted EBIT ($ in millions)
(i)
202412,432,742 14,261,834 4,296,305 4,152,650 261.47 102.76 950.1 1,055.2
202310,678,407 8,678,644 2,422,621 1,967,947 222.99 119.25 792.6 1,076.3
20229,947,560 (4,437,094)1,920,110 (1,740,310)258.84 119.13 540.2 1,021.3
202115,785,920 57,406,163 4,809,719 12,822,996 306.09 161.56 725.7 2,301.7
202010,079,870 20,796,543 2,725,275 4,370,754 149.58 136.78 312.9 1,396.5
       
Company Selected Measure Name Enterprise adjusted EBIT        
Named Executive Officers, Footnote Reflects compensation amounts reported in the “Summary Compensation Table” (“SCT”) Total compensation for our Chief Executive Officer, Andrew Rees. Refer to “Compensation Tables—Summary Compensation Table” (above).Reflects the average of the SCT Total compensation paid to our Non-PEO NEOs, as shown in our “Summary Compensation Table.” The non-PEO NEOs included in each year are as follows:
For 2020, Anne Mehlman, Daniel Hart, and Carrie Teffner.
For 2021, Anne Mehlman, Michelle Poole, Daniel Hart, and Elaine Boltz.
For 2022, Anne Mehlman, Michelle Poole, Elaine Boltz, Richard Blackshaw, and Adam Michaels.
For 2023, Anne Mehlman, Michelle Poole, Richard Blackshaw, and Adam Michaels.
For 2024, Anne Mehlman, Susan Healy, Terence Reilly, Adam Michaels, and Thomas Britt.
       
Peer Group Issuers, Footnote Represents the cumulative TSR of the Dow Jones U.S. Footwear Total Return Index (“Peer Group Cumulative TSR”), which is the published industry index used for purposes of Item 201(e) of Regulation S-K, weighted according to the respective companies’ stock market capitalization at the beginning of each period for which a return is indicated, for the years ended December 31, 2024, 2023, 2022, 2021, and 2020.        
PEO Total Compensation Amount $ 12,432,742 $ 10,678,407 $ 9,947,560 $ 15,785,920 $ 10,079,870
PEO Actually Paid Compensation Amount $ 14,261,834 8,678,644 (4,437,094) 57,406,163 20,796,543
Adjustment To PEO Compensation, Footnote Compensation actually paid (“CAP”) to our PEO reflects the SCT Total Compensation amounts set forth in column (b), adjusted as set forth in the table below, as calculated in accordance with applicable SEC rules. The dollar amounts reflected as CAP in column (c) of the table above do not reflect the actual amount of compensation earned or paid to our PEO during the applicable year. For information regarding pay decisions made by our Compensation Committee related to our PEO’s compensation for each fiscal year, refer to the Compensation Discussion and Analysis sections of the proxy statements reporting pay for the fiscal years covered in the table above. In accordance with the requirements of Item 402(v), the following amounts were deducted from and added to Mr. Rees’ SCT total compensation for fiscal year 2024 to determine the CAP. The Company does not provide pensions and accordingly no values are shown for Change in the Actuarial Value of Pension Benefits or Average Pension Benefit Adjustments.
2024
SCT Total Compensation for PEO$12,432,742 
Less: Equity Values Reported in SCT for the Covered Year
(8,549,916)
Add: Year-End Fair Value of Equity Compensation Granted in the Covered Fiscal Year that were Outstanding and Unvested at End of Covered Fiscal Year
7,155,843 
Adjust for: Change in Fair Value of Outstanding Awards Made in Prior Fiscal Years that were Outstanding Unvested at End of Covered Fiscal Year
(1,160,425)
Adjust for: Change in Fair Value of Awards Made in Prior Fiscal Years that Vested During Covered Fiscal Year
4,383,590 
Compensation Actually Paid to PEO$14,261,834 

PSU grant date fair values are calculated using the stock price as of the date of grant assuming target performance, and time-based RSU grant date fair values are calculated using the stock price as of the date of grant. The fair values of unvested and outstanding equity awards to our PEO for determining CAP were remeasured as of the end of each fiscal year, and as of each vesting date, as applicable, during the years displayed in the table above, calculated in accordance with applicable SEC rules.
       
Non-PEO NEO Average Total Compensation Amount $ 4,296,305 2,422,621 1,920,110 4,809,719 2,725,275
Non-PEO NEO Average Compensation Actually Paid Amount $ 4,152,650 1,967,947 (1,740,310) 12,822,996 4,370,754
Adjustment to Non-PEO NEO Compensation Footnote CAP to our non-PEO NEOs reflects the Average SCT Total Compensation for non-PEO NEOs amounts set forth in column (e), adjusted as set forth in the table below, as calculated in accordance with applicable SEC rules. The dollar amounts represented in column (d) do not reflect the actual amount of compensation earned by or paid to our non-PEO NEOs during the applicable year. For information regarding pay decisions made by our Compensation Committee related to our non-PEO NEOs’ compensation for each fiscal year, refer to the Compensation Discussion and Analysis sections of the proxy statements reporting pay for the fiscal years covered in the table above. In accordance with the requirements of Item 402(v), the following adjustments were made to average SCT total compensation for the non-PEO NEOs as a group for fiscal year 2024 to determine the CAP. The Company does not provide pensions and accordingly no values are shown for Change in the Actuarial Value of Pension Benefits or Average Pension Benefit Adjustments.
2024
SCT Total Compensation for Non-PEO NEOs$4,296,305 
Less: Equity Values Reported in SCT for the Covered Year
(2,921,893)
Add: Year-End Fair Value of Equity Compensation Granted in the Covered Fiscal Year that were Outstanding and Unvested at End of Covered Fiscal Year
2,596,678 
Adjust for: Change in Fair Value of Outstanding Awards Made in Prior Fiscal Years that were Outstanding and Unvested at End of Covered Fiscal Year
(70,389)
Adjust for: Change in Fair Value of Awards Made in Prior Fiscal Years that Vested During Covered Fiscal Year
251,949 
Compensation Actually Paid to Non-PEO NEOs$4,152,650 

PSU grant date fair values are calculated using the stock price as of the date of grant assuming target performance, and time-based RSU grant date fair values are calculated using the stock price as of the date of grant. The fair values of unvested and outstanding equity awards to our non-PEO NEOs for determining CAP were remeasured as of the end of each fiscal year, and as of each vesting date, as applicable, during the years displayed in the table above, calculated in accordance with applicable SEC rules.
       
Compensation Actually Paid vs. Total Shareholder Return
6730
       
Compensation Actually Paid vs. Net Income
6733
       
Compensation Actually Paid vs. Company Selected Measure
6736
       
Total Shareholder Return Vs Peer Group
6730
       
Tabular List, Table
Performance Measures
Enterprise Adjusted EBIT
Enterprise Adjusted Free Cash Flow
Revenue
Adjusted EBITDA Operating Margin
Corporate Responsibility and Sustainability Strategic Initiatives
       
Total Shareholder Return Amount $ 261.47 222.99 258.84 306.09 149.58
Peer Group Total Shareholder Return Amount 102.76 119.25 119.13 161.56 136.78
Net Income (Loss) $ 950,100,000 $ 792,600,000 $ 540,200,000 $ 725,700,000 $ 312,900,000
Company Selected Measure Amount 1,055,200,000 1,076,300,000 1,021,300,000 2,301,700,000 1,396,500,000
PEO Name Andrew Rees        
Additional 402(v) Disclosure Represents the cumulative total shareholder return (“TSR”) of Crocs, Inc. for the years ended December 31, 2024, 2023, 2022, 2021, and 2020. Cumulative TSR is calculated by dividing the sum of the cumulative amount of dividends for the measurement period (if any, and assuming dividend reinvestment, if applicable), and the difference between the Company’s share price at the end and the beginning of the measurement period by the Company’s share price at the beginning of the measurement period. TSR is cumulative for the measurement periods beginning on December 31, 2019, and ending on December 31 of each of 2024, 2023, 2022, 2021, and 2020, respectively.Reflects net income in the Company’s consolidated statements of operations in the Company’s Annual Reports on Form 10-K for the years ended December 31, 2024, 2023, 2022, 2021, and 2020.        
Measure:: 1          
Pay vs Performance Disclosure          
Name Enterprise Adjusted EBIT        
Non-GAAP Measure Description Company-selected performance measure is Enterprise adjusted EBIT, which is calculated by excluding interest expenses, tax expense, foreign currency changes and non-recurring entries from GAAP net income attributable to common stockholders, including costs to transition to our new HEYDUDE distribution center in Las Vegas, Nevada, impairment of information technology systems related to the HEYDUDE integration, impairment of the right-of-use assets for our former HEYDUDE Brand warehouses in Las Vegas, Nevada associated with our move to our new distribution center, and impairment of the right-of-use asset for our former Crocs Brand warehouse in Oudenbosch, the Netherlands.        
Measure:: 2          
Pay vs Performance Disclosure          
Name Enterprise Adjusted Free Cash Flow        
Measure:: 3          
Pay vs Performance Disclosure          
Name Revenue        
Measure:: 4          
Pay vs Performance Disclosure          
Name Adjusted EBITDA Operating Margin        
Measure:: 5          
Pay vs Performance Disclosure          
Name Corporate Responsibility and Sustainability Strategic Initiatives        
PEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ (8,549,916)        
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 7,155,843        
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (1,160,425)        
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 4,383,590        
Non-PEO NEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (2,921,893)        
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 2,596,678        
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (70,389)        
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 251,949        
v3.25.1
Award Timing Disclosure
12 Months Ended
Dec. 31, 2024
Award Timing Disclosures [Line Items]  
Award Timing MNPI Disclosure While we do not currently grant stock options or similar option-like instruments, such as stock appreciation rights, we are providing information regarding our procedures related to the grant of equity awards close in time to the release of material non-public information. We have not granted stock options since 2017.

While the Committee has generally determined to make our annual equity award grants at the regular meeting of the Committee held in the first quarter of each year, the Company does not have a formal policy or obligation that requires us to award equity or equity-based compensation on specific dates. Neither our Board nor our Compensation Committee takes material non-public information into account when determining the timing of equity awards, nor do we time the disclosure of material non-public information for the purpose of impacting the value of executive compensation. We generally issue equity awards to our executive officers on a limited and infrequent basis, and not in accordance with any fixed schedule. The Committee meeting date, or the next business day if the meeting falls on a day where the Nasdaq Global Select Market is closed for trading, is typically the effective grant date for the grants.

We also may grant equity awards to recognize increased responsibilities or special contributions, attract new hires, retain executives or recognize certain other special circumstances that occur throughout the year. The effective date of these grants is determined based on the timing of the recognition or recruitment event and approved on or in advance of the effective date of the grant. The exercise/grant price is the fair market value of our common stock on the effective date. The Committee approves all equity grants to executive officers. We do not permit repricing of stock options without stockholder approval.
Award Timing Method While we do not currently grant stock options or similar option-like instruments, such as stock appreciation rights, we are providing information regarding our procedures related to the grant of equity awards close in time to the release of material non-public information. We have not granted stock options since 2017.

While the Committee has generally determined to make our annual equity award grants at the regular meeting of the Committee held in the first quarter of each year, the Company does not have a formal policy or obligation that requires us to award equity or equity-based compensation on specific dates. Neither our Board nor our Compensation Committee takes material non-public information into account when determining the timing of equity awards, nor do we time the disclosure of material non-public information for the purpose of impacting the value of executive compensation. We generally issue equity awards to our executive officers on a limited and infrequent basis, and not in accordance with any fixed schedule. The Committee meeting date, or the next business day if the meeting falls on a day where the Nasdaq Global Select Market is closed for trading, is typically the effective grant date for the grants.

We also may grant equity awards to recognize increased responsibilities or special contributions, attract new hires, retain executives or recognize certain other special circumstances that occur throughout the year. The effective date of these grants is determined based on the timing of the recognition or recruitment event and approved on or in advance of the effective date of the grant. The exercise/grant price is the fair market value of our common stock on the effective date. The Committee approves all equity grants to executive officers. We do not permit repricing of stock options without stockholder approval.
Award Timing Predetermined false
Award Timing MNPI Considered true
Award Timing, How MNPI Considered While we do not currently grant stock options or similar option-like instruments, such as stock appreciation rights, we are providing information regarding our procedures related to the grant of equity awards close in time to the release of material non-public information. We have not granted stock options since 2017.

While the Committee has generally determined to make our annual equity award grants at the regular meeting of the Committee held in the first quarter of each year, the Company does not have a formal policy or obligation that requires us to award equity or equity-based compensation on specific dates. Neither our Board nor our Compensation Committee takes material non-public information into account when determining the timing of equity awards, nor do we time the disclosure of material non-public information for the purpose of impacting the value of executive compensation. We generally issue equity awards to our executive officers on a limited and infrequent basis, and not in accordance with any fixed schedule. The Committee meeting date, or the next business day if the meeting falls on a day where the Nasdaq Global Select Market is closed for trading, is typically the effective grant date for the grants.

We also may grant equity awards to recognize increased responsibilities or special contributions, attract new hires, retain executives or recognize certain other special circumstances that occur throughout the year. The effective date of these grants is determined based on the timing of the recognition or recruitment event and approved on or in advance of the effective date of the grant. The exercise/grant price is the fair market value of our common stock on the effective date. The Committee approves all equity grants to executive officers. We do not permit repricing of stock options without stockholder approval.
MNPI Disclosure Timed for Compensation Value false
v3.25.1
Insider Trading Policies and Procedures
12 Months Ended
Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true